|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | |
| A61K 39/395 |
| (11) | Number of the document | 2490720 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10825726.2 |
| Date of filing the European patent application | 2010-10-22 | |
| (97) | Date of publication of the European application | 2012-08-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/053686 |
| Date | 2010-10-22 |
| (87) | Number | WO 2011/050242 |
| Date | 2011-04-28 |
| (30) | Number | Date | Country code |
| 254474 P | 2009-10-23 | US |
| (72) |
NAM, Samuel, S., US
GREENFIELD, Edward, A., US
BABCOOK, John, CA
O`KEEFE, Theresa, US
QIN, Shixin, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
Amgen British Columbia, 7990 Enterprise Street, Burnaby, BC V5A 1V7, CA |
| (54) | ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |
| ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |